MedTrace Logo

A Clinical Study to Compare the Safety and Pharmacokinetics of CKD-320 and D012

NCT04035538 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2019-07-29

No results posted yet for this study

Summary

A clinical study to compare the safety and pharmacokinetics of CKD-320 and D012

Conditions

Interventions

DRUG

CKD-320, D012

R: D012 1tablet, QD, PO T: CKD-320 2tablets, QD, PO

Sponsors & Collaborators

  • Chong Kun Dang Pharmaceutical

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-31
Primary Completion
2019-11-30
Completion
2019-12-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04035538 on ClinicalTrials.gov